Glyprovac ApS on Muck Rack

Glyprovac ApS

As seen in: Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Glyprovac

Contact Glyprovac, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Glycosylation of bacterial antigens changes epitope patterns

|
By Glyprovac ApS, Branch Bioanalytics, Thomas Emil, Karolin Kern
| Frontiers
1 Introduction The Uropathogenic Escherichia coli (UPEC) is among the pathogens that exert the largest burden on public health and healthcare budgets in high-income countries (1). UPEC not only causes simple and recurrent urinary tract infections (UTIs), but also is associated with complicated UTIs. The lifetime incidence of a simple UTI is 50%–60% in adult women, and even with acute treatment, recurrence infections are confirmed within 6–12 months (2).
Open in Who Shared Issue with article?
See all 1 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified